State University of New York at Buffalo

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1846-05-11

Employees: 1K

Market Cap: -

Website: http://www.buffalo.edu

Clinical Trials

Effects of Dalfampridine on Cognition in Multiple Sclerosis

Phase 2

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: placebo
Drug: dalfampridine

First Posted Date: 2013-12-10

Last Posted Date: 2020-10-01

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 61

Registration Number: NCT02006160

Locations: 🇺🇸
Buffalo General Hospital, Buffalo, New York, United States

An Exercise App to Reduce Young Adults' MJ Use

Not Applicable

Completed

Conditions: Marijuana Smoking

Interventions: Behavioral: Personalized Feedback and Exercise

First Posted Date: 2013-05-27

Last Posted Date: 2016-02-01

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 36

Registration Number: NCT01863095

Locations: 🇺🇸
Center for Health Research, Buffalo, New York, United States

Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants

Phase 4

Completed

Conditions: Arrhythmias
Bradycardia

Interventions: Drug: Atropine

First Posted Date: 2013-03-27

Last Posted Date: 2023-04-06

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 60

Registration Number: NCT01819064

Locations: 🇺🇸
Women and Children's Hospital of Buffalo, Buffalo, New York, United States

Comparing the Laryngoscopy View Using Miller and Macintosh Laryngoscopy Blades in Infants Under Two Years of Age

Not Applicable

Completed

Conditions: Percent of Glottic Opening

Interventions: Device: Laryngoscope blade

First Posted Date: 2012-10-31

Last Posted Date: 2017-03-20

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 50

Registration Number: NCT01717872

Locations: 🇺🇸
Women and Childrens Hospital of Buffalo, Buffalo, New York, United States

Therapeutic Alliances in Alcoholism Treatment

Not Applicable

Completed

Conditions: Alcohol Use Disorders

Interventions: Behavioral: Cognitive-behavioral treatment

First Posted Date: 2012-09-20

Last Posted Date: 2022-04-27

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 166

Registration Number: NCT01689103

Locations: 🇺🇸
Research Institute on Addictions, Buffalo, New York, United States

Price Changes and Hypothetical Food Purchases in Adult Grocery Shoppers

Completed

Conditions: Effect of Taxes and Subsides on Food Purchases in Mothers

First Posted Date: 2012-06-14

Last Posted Date: 2017-01-10

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 217

Registration Number: NCT01619787

Locations: 🇺🇸
University at Buffalo, Buffalo, New York, United States

Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis

Phase 2

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: lisdexamfetamine sulfate
Drug: placebo

First Posted Date: 2012-06-11

Last Posted Date: 2022-09-16

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 63

Registration Number: NCT01615887

Locations: 🇺🇸
Kaleida Health, Jacobs Neurological Institute, Buffalo, New York, United States

Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Other: Placebo
Drug: Magnesium Sulfate

First Posted Date: 2012-05-14

Last Posted Date: 2020-10-22

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 261

Registration Number: NCT01597557

Locations: 🇺🇸
State University of New York at Buffalo, Buffalo, New York, United States

Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients

Phase 4

Completed

Conditions: Low Back Pain

Interventions: Drug: Methadone
Drug: Buprenorphine/naloxone

First Posted Date: 2012-03-21

Last Posted Date: 2020-11-03

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 19

Registration Number: NCT01559454

Locations: 🇺🇸
UB/MD Family Medicine, Inc., Amherst, New York, United States

The ChAMP (Chondral Lesions And Meniscus Procedures) Trial

Not Applicable

Completed

Conditions: Chondromalacia
Meniscal Tear

Interventions: Procedure: Arthroscopic debridement

First Posted Date: 2012-02-06

Last Posted Date: 2021-04-15

Lead Sponsor: State University of New York at Buffalo

Target Recruit Count: 190

Registration Number: NCT01527201

Locations: 🇺🇸
UB Orthopaedics and Sports Medicine, Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy